Intended for healthcare professionals

Latest dermatology news


J&J gains rights to atopic dermatitis candidate through $1.25bn Yellow Jersey acquisition

Approximately 70% of patients with the inflammatory skin disease do not achieve remission with current therapies

20 Jun 2024

Typharm’s Nystaform advised by DHSC for skin infections caused by fungi and bacteria

Nystaform HC Cream is indicated to treat skin infections including ringworm and athlete’s foot

13 Jun 2024

Moderna/Merck’s investigational skin cancer vaccine shows promise in high-risk melanoma

The companies have been evaluating the candidate in combination with Merck’s Keytruda

13 Jun 2024

Almirall survey highlights limited knowledge of actinic keratosis

The survey revealed that half of Europe’s population gets sunburned at least once a year

07 Jun 2024

J&J advances dermatology portfolio through $850m Proteologix acquisition

The company will gain access to two atopic dermatitis treatments and other bispecific antibody programmes

30 May 2024

New treatment found to reverse hair loss caused by alopecia areata

The microneedle patch is made from hyaluronic acid crosslinked with polyethylene glycol

24 May 2024

LEO reports positive late-stage results for Enstilar in adults with stable plaque psoriasis

The aerosol spray foam was superior to LEO’s Daivobet ointment in the trial’s primary endpoint

16 May 2024

UCB receives EC approval for Bimzelx in hidradenitis suppurativa

The therapy is already approved in the EU to treat plaque psoriasis, psoriatic arthritis and axial spondyloarthritis

09 May 2024

UK study uncovers two genes offering potential drug targets against skin cancer

Scientists believe that both genes could be targeted to prevent melanoma from metastasising

02 May 2024

UCB shares positive late-stage results for Bimzelx in plaque psoriasis

Bimzelx works to inhibit two cytokines that drive inflammatory processes

25 Apr 2024